FEA, Biomechanical and Clinical Study of R.O. Peritrochanteric Fractures With PFLP vs Cephalomedullary Nail.

Launched by UNIVERSITY GENERAL HOSPITAL OF PATRAS · Mar 9, 2022

Keywords

ClinConnect Summary

This clinical trial is studying two different surgical methods for treating a specific type of hip fracture called a reverse oblique pertrochanteric fracture. The researchers want to compare the effectiveness and safety of using a special plate called the Proximal Femur Locking Plate (PFLP) versus a commonly used rod called the cephalomedullary nail. The goal is to find out which method leads to better healing and recovery for patients, particularly looking at factors like how well the bones align after surgery and how patients feel in terms of pain and mobility up to six months later.

To be eligible for this study, patients need to be over 65 years old and have a closed hip fracture that happened due to a fall or trauma. They should come to the hospital within a week of their injury and not have any other significant injuries or previous surgeries on the same hip. Participants will be monitored and evaluated after their surgery to see how well they recover and regain their independence. This trial is currently recruiting participants, and it's important for potential candidates to understand that their involvement will help improve treatment options for future patients with similar fractures.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. A31-1,3 intertrochanteric fracture ( AO classification) due to trauma, closed injury.
• • 2. Patients over 65 years of age
• • 3. Presentation in the hospital within 7 days from the fracture
• • 4. There are no concomitant injuries or previous operations on the unaffected hip
• Exclusion Criteria:
• • 1. Patients with concomitant injuries that affect the treatment and rehabilitation of the affected limb
• • 2. Patients with associated neurovascular injuries requiring immediate surgery
• • 3. Patients with limited Greek language proficiency, including family members
• • 4. Patients who refuse to sign admission consent to the study
• • 5. Patients with severe dementia, bedridden and severe comorbidities that are a contraindication to surgery